Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9087861 | 0.84 | KMT2A (0.58) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL9331809 | 0.82 | KMT2A (0.67) | LMNAKMT2AALDH1A1HPGDMAPK1 | |
| SCHEMBL9994163 | 0.82 | ALDH1A1 (0.49) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL3737213 | 0.81 | ALDH1A1 (0.44) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL9088392 | 0.81 | KMT2A (0.55) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL10769901 | 0.80 | KMT2A (0.41) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL10403341 | 0.76 | KMT2A (0.44) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL8316778 | 0.76 | KMT2A (0.58) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL10403907 | 0.75 | KMT2A (0.43) | LMNAKMT2ANPC1ALDH1A1HPGD | |
| SCHEMBL10403909 | 0.75 | KMT2A (0.43) | LMNAKMT2ANPC1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6420554-B1 | REACTION OF BETA LACTAM WITH PHOSPHOROUS HALIDE IN THE PRESENCE OF BASE, ADDING PHENOL, REACTION WITH ALCOHOL AND REMOVAL OF ESTER | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2002-07-16 | — | — | US | claimed |
| US-4547573-A | BACTERICIDES | ICI PHARMA (FR) | 1985-10-15 | — | — | US | claimed |
| US-4504478-A | Cephalosporin-1-oxide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (FR) | 1985-03-12 | — | — | US | claimed |
| US-4497949-A | PHOTOTHERMOGRAPHY;COLOR FILMS;STORAGE STABILITY;ANTIFOGGING AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-02-05 | — | — | US | claimed |
| US-4492692-A | BACTERICIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-01-08 | — | — | US | claimed |
| US-4463173-A | ANTIBIOTIC, BACTERICIDE | ICI PHARMA (FR) | 1984-07-31 | — | — | US | claimed |
| EP-0113965-A2 | Process for the preparation of cephalosporin derivatives | ICI PHARMA (FR) | 1984-07-25 | — | — | EP | claimed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0072608-A2 | Process for the preparation of cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-02-23 | — | — | EP | claimed |
| US-7825238-B2 | Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine | MEDIVIR AB (SE) | 2010-11-02 | — | — | US | disclosed |
| EP-1010701-B1 | PROCESS FOR THE PREPARATION OF 3-CEPHEM COMPOUNDS | OTSUKA KAGAKU KK (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-20070111980-A1 | Process for preparing pure cephalosporine intermediates | HETERO DRUGS LIMITED (IN) | 2007-05-17 | — | — | US | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-4251657-A | Method for removing protective groups | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-02-17 | — | — | US | disclosed |
| US-4180571-A | Arylmalonamido-1-oxadethiacephalosporins | SHIONOGI & CO., LTD. (JP) | 1979-12-25 | — | — | US | disclosed |
| EP-0003960-A1 | 6-Substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-09-19 | — | — | EP | disclosed |
| EP-0002586-A1 | Method for removing a halogenoacetyl protective group from a halogenoacetyl amino compound | Takeda Chemical Industries, Ltd. (JP) | 1979-06-27 | — | — | EP | disclosed |
| US-4138486-A | BACTERICIDES | SHIONOGI & CO., LTD. (JP) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111980-A1 | Process for preparing pure cephalosporine intermediates | ACMSD, CEL, MGAM | LMNA 1502/4885KMT2A 690/4885NPC1 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.